Johnson & Johnson MedTech has announced the U.S. launch of the VIRTUGUIDE™ System, following the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pre-operative Planning Software. This AI-powered, patient-matched solution is designed to simplify the Lapidus procedure, a type of bunion surgery. Early reports indicate that the system can reduce surgical time by 30 minutes compared to traditional methods. The VIRTUGUIDE™ System, developed in collaboration with PeekMed®, is now available in the U.S., marking a significant advancement in surgical precision for bunion deformities.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。